Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;15(9):2205-2216.
doi: 10.1080/21645515.2019.1581542. Epub 2019 Apr 19.

Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence

Affiliations
Review

Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence

Justine Alderfer et al. Hum Vaccin Immunother. 2019.

Abstract

Invasive meningococcal disease (IMD), a rapidly progressing and potentially fatal illness, disproportionately affects adolescents and young adults. While IMD is best prevented by vaccination, vaccine uptake in these groups is low. An evidence-based understanding of the safety and effectiveness of concomitant vaccination of meningococcal vaccines, including the newer MenB protein vaccines and the more established MenACWY conjugate vaccines, with other vaccines recommended for adolescents and young adults may help maximize vaccination opportunities. We identified 21 studies assessing concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults. Although studies varied in methodology, concomitant administration generally did not affect immunogenicity of the meningococcal or coadministered vaccines. In some cases, reactogenicity increased following concomitant administration, but no definitive safety concerns were raised. In general, data suggest that meningococcal vaccines can be safely and effectively coadministered with other vaccines.

Keywords: Invasive meningococcal disease; MenB-FHbp; adolescents; adults; concomitant; vaccination.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Selection of articles for inclusion.

Similar articles

Cited by

References

    1. Stein-Zamir C, Shoob H, Sokolov I, Kunbar A, Abramson N, Zimmerman D.. The clinical features and long-term sequelae of invasive meningococcal disease in children. Pediatr Infect Dis J. 2014;33(7):777–79. doi:10.1097/INF.0000000000000282. - DOI - PubMed
    1. Baccarini C, Ternouth A, Wieffer H, Vyse A. The changing epidemiology of meningococcal disease in North America 1945-2010. Hum Vaccin Immunother. 2013;9(1):162–71. doi:10.4161/hv.22302. - DOI - PMC - PubMed
    1. Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, Harnden A, Mant D, Levin M. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397–403. doi:10.1016/S0140-6736(06)67932-4. - DOI - PubMed
    1. Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(suppl 2):B3–B9. doi:10.1016/j.vaccine.2011.12.062. - DOI - PubMed
    1. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27(suppl 2):B51–63. doi:10.1016/j.vaccine.2009.04.063. - DOI - PubMed

Publication types